About Galyx Therapeutics
Pioneering galectin inhibition to transform cancer therapeutics.
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Laval, Quebec
- Company type
- Privately Held
Galyx Therapeutics is a pre-clinical biotechnology company advancing next-generation glyco-immune checkpoint inhibitors targeting galectins for cancer. Building on over 25 years of research, our approach focuses on disrupting galectin-mediated immune suppression in the tumor microenvironment to enable more effective immune responses.
Company locations
500 Boulevard Cartier O, Laval, Quebec H7V 5B7, CA
Locations listed on the company profile. These may include offices outside Canada, and not every location is hiring.
On LinkedIn
- Followers
- 94
- People linked to this company
- 3
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.